Stockreport

RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum [Yahoo! Finance]

RenovoRx, Inc.  (RNXT) 
PDF RenovoRx, Inc. Over the past year, RenovoRx has Tripled Commercially Active U.S. Cancer Centers and Centers Requesting Access to RenovoCath, its FDA-Cleared Device [Read more]